![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 2.
Journal article
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Vol. 19, No. 9: pp. 1215-1228
Fischer, Kirsten; Al-Sawaf, Othman; Fink, Anna-Maria; Dixon, Mark; Bahlo, Jasmin; Warburton, Simon; Kipps, Thomas J.; Weinkove, Robert; Robinson, Sue; Seiler, Till; Opat, Stephen; Owen, Carolyn; Lopez, Javier; Humphrey, Kathryn; Humerickhouse, Rod; Tausch, Eugen; Frenzel, Lukas; Eichhorst, Barbara; Wendtner, Clemens-M.; Stilgenbauer, Stephan; Langerak, Anton W.; Dongen, Jacque J. M. van; Böttcher, Sebastian; Ritgen, Matthias; Göde, Valentin; Mobasher, Mehrdad und Hallek, Michael
(2017):
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
In: Blood, Vol. 129, No. 19: pp. 2702-2705